Bioactive baculovirus nanohybrids for stent based rapid vascular re-endothelialization

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Paul, Arghya ^a,d   Elias, Cynthia B ^b   Shum Tim, Dominique ^c   Prakash, Satya ^a  

^a MCGILL UNIVERSITY   (Canada)

^b Sanofi Pasteur   (Canada)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^d HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN A;

ANIMAL; ARTICLE; BACULOVIRUS; BLOOD VESSEL PROSTHESIS; DOG; EQUIPMENT; EQUIPMENT FAILURE; FEMORAL ARTERY; GENETIC TRANSDUCTION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METHODOLOGY; NANOTECHNOLOGY; PHYSIOLOGY; PROSTHESIS; REGENERATION; STENT; BACULOVIRIDAE; DEVICE FAILURE ANALYSIS; DEVICES; PROCEDURES; SURGERY;

ANIMALS; BACULOVIRIDAE; BLOOD VESSEL PROSTHESIS; DOGS; EQUIPMENT FAILURE ANALYSIS; FEMORAL ARTERY; NANOTECHNOLOGY; PROSTHESIS DESIGN; REGENERATION; STENTS; TRANSDUCTION, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84881603049     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep02366     Document Type: Article

References (40)

1. Cully, M. Treating restenosis after drug-eluting stent implantation. Nat Rev Cardiol 10, 62 (2013).
2. van der Heiden, K. et al. The effects of stenting on shear stress: relevance to endothelial injury and repair. Cardiovasc Res (2013).
3. Dangas, G. D. et al. In-stent restenosis in the drug-eluting stent era. J Am Coll Cardiol 56, 1897-1907 (2010).
4. Paul, A., Shao, W., Shum-Tim, D. & Prakash, S. The attenuation of restenosis following arterial gene transfer using carbon nanotube coated stent incorporating TAT/DNA(Ang1 1 Vegf) nanoparticles. Biomaterials 33, 7655-7664 (2012).
5. Chan, J. M. et al. In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid-polymeric nanoparticles. Proc Natl Acad Sci USA 108, 19347-19352 (2011).
6. Langer, R. & Tirrell, D. A. Designing materials for biology and medicine. Nature 428, 487-492 (2004).
7. Prakash, S., Malhotra, M., Shao, W., Tomaro-Duchesneau, C. & Abbasi, S. Polymeric nanohybrids and functionalized carbon nanotubes as drug delivery carriers for cancer therapy. Adv Drug Deliv Rev 63, 1340-1351 (2011).
8. Binsalamah, Z. M., Paul, A., Prakash, S. & Shum-Tim, D. Nanomedicine in cardiovascular therapy: recent advancements. Expert Rev Cardiovasc Ther 10, 805-815 (2012).
9. Shuchman, M. Debating the risks of drug-eluting stents. N Engl J Med 356, 325-328 (2007).
10. Iakovou, I. et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293, 2126-2130 (2005).
11. Mitragotri, S. & Lahann, J. Materials for drug delivery: innovative solutions to address complex biological hurdles. Adv Mater 24, 3717-3723 (2012).
12. Holmes, D. R. Jr. Incidence of late stent thrombosis with bare-metal, sirolimus, and paclitaxel stents. Rev Cardiovasc Med 8 Suppl 1, S11-18 (2007).
13. Goh, D. et al. Nanotechnology-based gene-eluting stents. Mol Pharm 10, 1279-1298 (2013).
14. Tan, A. et al. Inception to actualization: next generation coronary stent coatings incorporating nanotechnology. J Biotechnol 164, 151-170 (2013).
15. Neumeister, A. et al. Interface of nanoparticle-coated electropolished stents. Langmuir 28, 12060-12066 (2012).
16. Saurer, E. M. et al. Polyelectrolyte Multilayers Promote Stent-Mediated Delivery of DNA to Vascular Tissue. Biomacromolecules (2013).
17. Nakano, K. et al. Formulation of nanoparticle-eluting stents by a cationic electrodeposition coating technology: efficient nano-drug delivery via bioabsorbable polymeric nanoparticle-eluting stents in porcine coronary arteries. JACC Cardiovasc Interv 2, 277-283 (2009).
18. Zhu, D. et al. Local gene delivery via endovascular stents coated with dodecylated chitosan-plasmid DNA nanoparticles. Int J Nanomedicine 5, 1095-1102 (2010).
19. Gaharwar, A. K. et al. Bioactive Silicate Nanoplatelets for Osteogenic Differentiation of Human Mesenchymal Stem Cells. Adv Mater (2013).
20. Sharif, F. et al. Gene-eluting stents: adenovirus-mediated delivery of eNOS to the blood vessel wall accelerates re-endothelialization and inhibits restenosis. Mol Ther 16, 1674-1680 (2008).
21. Yang, J. et al. The prevention of restenosis in vivo with a VEGF gene and paclitaxel co-eluting stent. Biomaterials 34, 1635-1643 (2013).
22. Hiltunen, M. O. et al. Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta. Circulation 102, 2262-2268 (2000).
23. Paul, A., Shao, W., Abbasi, S., Shum-Tim, D. & Prakash, S. PAMAM dendrimer-baculovirus nanocomplex for microencapsulated adipose stem cell-gene therapy: in vitro and in vivo functional assessment. Mol Pharm 9, 2479-2488 (2012).
24. Paul, A. et al. A nanobiohybrid complex of recombinant baculovirus and Tat/DNA nanoparticles for delivery of Ang-1 transgene in myocardial infarction therapy. Biomaterials 32, 8304-8318 (2011).
25. Paul, A., Nayan, M., Khan, A. A., Shum-Tim, D. & Prakash, S. Angiopoietin-1-expressing adipose stem cells genetically modified with baculovirus nanocomplex: investigation in rat heart with acute infarction. Int J Nanomedicine 7, 663-682 (2012).
26. Shiojima, I. & Walsh, K. The role of vascular endothelial growth factor in restenosis: the controversy continues. Circulation 110, 2283-2286 (2004).
27. Lesch, H. P. et al. Requirements for baculoviruses for clinical gene therapy applications. J Invertebr Pathol 107 Suppl, S106-112 (2011).
28. Kaikkonen, M. U., Maatta, A. I., Yla-Herttuala, S. & Airenne, K. J. Screening of complement inhibitors: shielded baculoviruses increase the safety and efficacy of gene delivery. Mol Ther 18, 987-992 (2010).
29. Newman, K. D. et al. Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. J Clin Invest 96, 2955-2965 (1995).
30. Kim, Y.-K., Jiang, H.-L., Je, Y.-H., Cho, M.-H. & Cho, C.-S. Modification of baculovirus for gene therapy. Communicating Current Research and Educational Topics and Trends in Applied Microbiology Vol. II, 875-884 (2007).
31. van Oers, M. M. Opportunities and challenges for the baculovirus expression system. J Invertebr Pathol 107 Suppl, S3-15 (2011).
32. Balmert, S. C. & Little, S. R. Biomimetic delivery with micro-and nanoparticles. Adv Mater 24, 3757-3778 (2012).
33. Soike, T. et al. Engineering a material surface for drug delivery and imaging using layer-by-layer assembly of functionalized nanoparticles. Adv Mater 22, 1392-1397 (2010).
34. Matthews, C., Jenkins, G., Hilfinger, J. & Davidson, B. Poly-L-lysine improves gene transfer with adenovirus formulated in PLGA microspheres. Gene Ther 6, 1558-1564 (1999).
35. McKenna, C. J. et al. Fibrin-film stenting in a porcine coronary injury model: efficacy and safety compared with uncoated stents. J Am Coll Cardiol 31, 1434-1438 (1998).
36. Slaughter, B. V., Khurshid, S. S., Fisher, O. Z., Khademhosseini, A. & Peppas, N. A. Hydrogels in regenerative medicine. Adv Mater 21, 3307-3329 (2009).
37. Macaya, D., Ng, K. K. & Spector, M. Injectable Collagen-Genipin Gel for the Treatment of Spinal Cord Injury: In Vitro Studies. Advanced Functional Materials 21, 4788-4797 (2011).
38. Welt, F. G., Edelman, E. R., Simon, D. I. & Rogers, C. Neutrophil, not macrophage, infiltration precedes neointimal thickening in balloon-injured arteries. Arterioscler Thromb Vasc Biol 20, 2553-2558 (2000).
39. Schwartz, R. S. et al. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol 19, 267-274 (1992).
40. Montanez, R., Sanchez-Jimenez, F., Quesada, A. R. & Medina, M. A. Exploring and challenging the network of angiogenesis. Sci Rep 1, 61 (2011).